Skip to main content

Table 3 Patient's characteristics of matched HIV-seropositive patients and HIV-seronegative patients matched for TNM-stage and age (n = 10 vs. 10).

From: Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy

Variable

Study group

Fisher's exact test

 

HAART-HIV +

HIV -

 

gender

m:f = 9:1 (90%)

m:f = 1:9 (10%)

0.001

age (mean)

44.5 +/- 10 y

45.2 +/- 7 y

NS

WHO-perform. Status I°

2 (20 %)

0

NS

T1

2

2

NS

T2

6

6

NS

T3

2

2

NS

N0

9

9

NS

N2

1

1

NS

G1

2

 

NS

G2

6

8

NS

G3

 

2

NS

Sphincter invasion

2 (22 %)

3 (30 %)

NS

Histology (basaloid)

2 (20 %)

4 (40 %)

NS

Mitomycin C

6 (60 %)

8 (80 %)

NS

Brachytherapy

0 (0 %)

6 (60 %)

0.005

RT-dose (mean)

57.7 +/- 2.4 Gy

58.5 +/- 3 Gy

NS

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us